Ginkgo Bioworks Holdings (DNA) Cash from Investing Activities (2020 - 2026)

Ginkgo Bioworks Holdings has reported Cash from Investing Activities for 7 years, with the latest figure at $23.1 million in Q1 2026.

• For the quarter ending Q1 2026, Cash from Investing Activities rose 111.64% year-over-year to $23.1 million; the trailing twelve-month figure through Mar 2026 stood at -$18.5 million (up 92.58% YoY), and the FY2025 full-year result was -$240.3 million, down 286.09% from the prior year.
• Cash from Investing Activities for Q1 2026 stood at $23.1 million, down from $95.1 million in the prior quarter.
• The five-year high for Cash from Investing Activities was $95.1 million in Q4 2025, with the low at -$198.7 million in Q1 2025.
• Historically, Cash from Investing Activities has averaged -$25.1 million across 5 years, with a median of -$14.7 million in 2022.
• The largest YoY upside for Cash from Investing Activities was 826.78% in 2025 against a maximum downside of 1540.66% in 2025.
• Ginkgo Bioworks Holdings' Cash from Investing Activities stood at $29.7 million in 2022, then tumbled by 256.94% to -$46.7 million in 2023, then surged by 71.97% to -$13.1 million in 2024, then surged by 826.78% to $95.1 million in 2025, then tumbled by 75.68% to $23.1 million in 2026.
• The last three Cash from Investing Activities figures came in at $23.1 million (Q1 2026), $95.1 million (Q4 2025), and -$72.8 million (Q3 2025), per Business Quant data.